Lannett Co Inc (LCI): Price and Financial Metrics

LCI POWR Grades

• Value is the dimension where LCI ranks best; there it ranks ahead of 96.59% of US stocks.
• The strongest trend for LCI is in Value, which has been heading up over the past 179 days.
• LCI ranks lowest in Momentum; there it ranks in the 8th percentile.

LCI Stock Summary

• LCI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.24 -- higher than just 1.84% of US-listed equities with positive expected earnings growth.
• With a price/sales ratio of 0.09, Lannett Co Inc has a higher such ratio than merely 0.71% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -36.81 for Lannett Co Inc; that's greater than it is for only 0.66% of US stocks.
• Stocks that are quantitatively similar to LCI, based on their financial statements, market capitalization, and price volatility, are CHNG, SGMS, NGVT, AVCT, and KOS.
• Visit LCI's SEC page to see the company's official filings. To visit the company's web site, go to www.lannett.com.

LCI Valuation Summary

• LCI's price/sales ratio is 0.3; this is 97.36% lower than that of the median Healthcare stock.
• LCI's price/earnings ratio has moved down 37.7 over the prior 243 months.
• Over the past 243 months, LCI's price/sales ratio has gone down 2.4.

Below are key valuation metrics over time for LCI.

LCI Growth Metrics

The 4 year revenue growth rate now stands at 14.55%.
• The year over year revenue growth rate now stands at -5.72%.
• Its 4 year price growth rate is now at -60.48%.

Over the past 52 months, LCI's revenue has gone down $220,331,000.

The table below shows LCI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	406.412	99.284	-288.455
2021-09-30	453.824	90.275	-379.318
2021-06-30	478.778	60.851	-363.475
2021-03-31	510.689	99.838	-195.29
2020-12-31	542.691	43.71	-204.74
2020-09-30	544.881	99.526	-27.708

LCI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• LCI has a Quality Grade of C, ranking ahead of 38.22% of graded US stocks.
• LCI's asset turnover comes in at 0.579 -- ranking 62nd of 682 Pharmaceutical Products stocks.
• AWH, DRRX, and CLSN are the stocks whose asset turnover ratios are most correlated with LCI.

The table below shows LCI's key quality metrics over time.